home / stock / trvn / trvn articles


TRVN Articles, Trevena Inc. - From 06/21/24

Stock Information

Company Name: Trevena Inc.
Stock Symbol: TRVN
Market: NASDAQ
Website: trevena.com

Menu

TRVN TRVN Quote TRVN Short TRVN News TRVN Articles TRVN Message Board
Get TRVN Alerts

News, Short Squeeze, Breakout and More Instantly...

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in today's pre-market trading after the company announced expanded US FDA appr...

Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining more than 300 points on Thursday. The Dow traded up 0.87% to 3...

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 20...

What's Going On With Neurological Disease Focused Trevena On Thursday? | Benzinga

Shares of Trevena Inc (NASDAQ:TRVN) are trading lower on Thursday, with a session volume of 23.65 million, as per data from Benzinga Pro. The compa...

Gold Rises 1%; Accenture Shares Surge After Q3 Results | Benzinga

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 50 points on Thursday. Following the market opening Thursd...

Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise | Benzinga

CHESTERBROOK, Pa., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. ("Trevena" or the "Company") (NASDAQ:TRVN), a biopharmaceutical company focus...

Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting | Benzinga

-- Presentation highlighted promising results of TRV045 in nonclinical models of neuropathic pain including mechanical and cold-stimulus evoked no...

Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries | Benzinga

CHESTERBROOK, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and com...

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter. UP Fintech Holdi...

Trevena to Release Third Quarter 2023 Financial Results on November 14, 2023 | Benzinga

CHESTERBROOK, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and com...

Previous 10 Next 10